Macular edema is the condition when the fluid and proteins start collecting on or under the macula of the eye thereby resulting in swelling. Due to such swelling, a person’s central eye vision gets distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME).
Read Report Overview – https://www.transparencymarketresearch.com/diabetic-macular-edema-market.html
Diabetic macular edema is the major reason for loss of vision in patients suffering from diabetic retinopathy. Diabetes patient are reported to have a 10% risk of developing this condition during their lifetime. On the basis of the cause of disease, DME is classified into two types:
Diffuse macular edema: due to abnormalities in dilated capillaries present in the retina.
Request for Report Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2248
Focal macular edema: due to abnormalities in microaneurysms
For diagnosing diabetic macular edema, an ophthalmologist checks the retina for symptoms of the disease including leaking blood vessel, retinal swelling, damaged nerve tissues and pale, fatty deposits on the retina. For further confirmation, comprehensive eye examination such as visual acuity test, dilated exam test and tonometry are performed.
During the initial stages of DME, no treatment is needed unless the patients efficiently control their blood sugar levels. If the condition becomes severe, the standard treatment for diabetic macular edema is laser photocoagulation. This procedure utilizes laser to reduce edema by applying a pattern of burnsor bycauterizing leaky blood vessels.
Request for Analysis of COVID19 Impact on Diabetic Macular Edema Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2248
For avoiding the side-effects of this treatment, retinal specialists apply injections of anti-vascular endothelial growth factor corticosteroids along with laser photocoagulation. Currently, there are only two approved drugs available in market for treating DME namely Lucentis and Ozurdex. Other treatment methods are currently under clinical trials.
The markets for America and Europe are at the maturity stage for diabetic macular edema because large proportion of population is suffering from diabetes. Lucentis and Ozurdex ocuppy the major part of the market share in the therapeutics market. Asia-Pacific is also growing at faster pace while the markets of Africa and Australia are currently at initial stages.
Pre Book Diabetic Macular Edema Market Research – https://www.transparencymarketresearch.com/checkout.php?rep_id=2248<ype=S
Some of the companies and institutes which are involved in clinical trials for treatment of diabetic macular edema are Allergan, Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., Pfizer, Inc., Bayer AG, Bausch & Lomb Incorporated, the Diabetic Retinopathy Clinical Research Network, The National Eye Institute, Johns Hopkins University and Shahid Beheshti University of Medical Sciences.
More Trending Reports by Transparency Market Research –
Antimicrobial Ingredients Market: https://www.biospace.com/article/antimicrobial-ingredients-market-high-demand-for-antibacterial-agents-to-drive-market-growth-through-2026/
Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
